why choose us

First received: August 11, 2023

Clinical Trial: Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Ovarian High Grade Serous Adenocarcinoma

Study Type: INTERVENTIONAL


Official Title: Phase II Clinical Trial Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

Brief Summary: This phase II trial test tests how well repurposing atovaquone works in treating patients with platinum-resistant ovarian cancer.Atovaquone is used for the treatment or prevention of certain infections.Atovaquone is in a class of medications called antiprotozoal agents.It works by stopping the growth of certain types of protozoa that can cause pneumonia.Giving atovaquone may be effective in treating platinum-resistant ovarian cancer and result in improved outcomes compared to standard chemotherapy regimens.

Read more